Wichaidit BT, Østergaard JR, Rask CU. Epilepsia 2015;56:58-65. OBJECTIVE: No formal guidelines for diagnosing psychogenic nonepileptic seizures (PNES) in children exist, and little is known about the clinical practice of diagnosing PNES in the pediatric setting. We therefore performed a national survey as a first step to document pediatricians' current diagnostic practice for PNES. METHODS: A questionnaire was distributed to all pediatricians (n = 64) working in the field of neuropediatrics and/or social pediatrics in the Danish hospital setting to uncover their use of terminology and of the International Classification of Diseases, 10th Revision (ICD-10) codes as well as their clinical diagnostic approach to pediatric PNES. The questionnaire included questions on 18 history and 24 paroxysmal event characteristics. RESULTS: The response rate was 95% (61/64). There was no consensus on which terminology and diagnostic codes to use. Five history characteristics (psychosocial stressors/trauma, sexual abuse, paroxysmal events typically occur in stressful situations, no effect of antiepileptic drugs, and physical abuse) and six paroxysmal event characteristics (resisted eyelid opening, avoidance/guarding behavior, paroxysmal events occur in the presence of others, closed eyes, rarely injury related to paroxysmal event, and absence of postictal change) were agreed to be very predictive of PNES by at least 50% of the pediatricians. Supplementary diagnostic tests such as blood chemistry measurements (e.g., blood glucose or acute phase reactants; i.e., white blood cell count and C-reactive protein) and electrocardiography were inconsistently used. Only 49% of the respondents reported to use video-electroencephalography (VEEG) frequently as part of their diagnostic procedure. SIGNIFICANCE: To our knowledge, this is the first national survey that offers a systematic insight into the diagnostic practices for children with PNES in the hospital setting. The results demonstrate a need for clinical guidelines to improve and systematize the diagnostic approach for PNES in children.
OBJECTIVE: Psychogenic nonepileptic seizures (PNES) in youth are symptoms of a difficult to diagnose and treat conversion disorder. PNES is associated with high medical and psychiatric morbidity, but specific PNES risk factors in the pediatric population are not known. We examined if youth with PNES have a distinct biopsychosocial risk factor profile compared to their siblings and if the interrelationships between these risk factors differentiate the PNES probands from the sibling group. METHODS: This multisite study included 55 youth with a confirmed diagnosis of PNES (age range 8.6-18.4 years) and their 35 sibling controls (age range 8.6-18.1 years). A video EEG and psychiatric assessment confirmed the PNES diagnosis. Parents reported on each child's past and present medical/epilepsy, psychiatric, family, and educational history. Each child underwent a structured psychiatric interview, standardized cognitive and academic achievement testing, and completed self-report coping, daily stress, adversities, and parental bonding questionnaires. RESULTS: Compared to their siblings, the PNES probands had significantly more lifetime comorbid medical, neurological (including epilepsy), and psychiatric problems; used more medications and intensive medical services; had more higher anxiety sensitivity, practiced solitary emotional coping, and experienced more lifetime adversities. A principal components analysis of these variables identified a somatopsychiatric, adversity, epilepsy, and cognitive component. The somatopsychiatric and adversity components differentiated the probands from the siblings, and were highly significant predictors of PNES with odds ratios of 15.1 (95% CI [3.4, 67.3], and 9.5 (95% CI [2.0, 45.7]), respectively. The epilepsy and cognitive components did not differentiate between the PNES and sibling groups. SIGNIFICANCE: These
Psychogenic Nonepileptic Seizures: Children Are Not Miniature Adults
Commentary Psychogenic nonepileptic seizures (PNES) are paroxysmal events that are not correlated with underlying electrical discharges in the brain. Most of the literature on this topic has focused on PNES in adults, as they are more commonly recorded in adult epilepsy monitoring units (EMU). While the prevalence is greater in adults (1), PNES occur at nearly all ages, including children as young as 8 years of age. Data obtained on adults with PNES, such as prevalent physical and sexual abuse (1, 2) , are commonly misapplied to children with PNES, despite growing evidence gathered over the years that PNES in children are clearly different. Even neurologists with special interest in PNES have not appreciated the significant differences in this population.
There are several examples of differences between pediatric and adult PNES. Most significantly, school difficulties or family adversity predominate as the major risk factors in children, rather than physical or sexual trauma (1, 2) . The delivery of the diagnosis of PNES is a vulnerable time for children and their families, where critical follow-up may be abandoned if it is not handled in a sensitive manner. Clinicians may inadvertently alienate parents who are not prepared for the psychiatric implications of the diagnosis. Another difference between PNES in adults and children is the semiology of the events. Semiology is more commonly nonmotor in children, rather than convulsive, opisthotonic, or pelvic thrusting (3, 4) . Prognosis may also be different. Adults have low return to employment, with about 50% on disability, and only about 33% become "event free." Outcomes for symptom control are reported as much better in children (5) , with approximately 80% becoming event free. However, freedom from events is quite different than freedom from disability and having a good quality of life. The psychosocial disabilities that are a prominent part of PNES are more likely to remain when appropriate treatment is not followed, and this is likely the most troubling aspect of pediatric PNES. Tracking more than just seizure freedom is needed to understand how these children fare in the long term. The adverse effects of anti-epileptic drugs for children may include interference with learning and, therefore, any unnecessary medication should be removed. With the delay to diagnosis of approximately 3.5 years for pediatric PNES, this can translate to prolonged exposure to medications and further developmental difficulties. Investigating all of the various events is critical so that anti-epileptic drugs can be removed if at all possible.
Therefore, trying to understand PNES in children by looking at the adult literature is not likely to be helpful. Two recent studies published in Epilepsia this year focus specifically on children with PNES and shed light on this important topic. Wichaidit and coauthors administered a survey to Danish pediatricians focused on PNES and found that only 49% reported using video EEG for definitive diagnosis of spells and very rarely or never arranged for brain MRI in the majority of cases. Diagnosis can be quite difficult in children given the common occurrence of non-motor semiologies and the wide differential which can include attention deficit disorder, oppositional behavior, etc. Since diagnosis is more difficult in children, this result is rather surprising. In this study, the majority of pediatricians used multiple and inconsistent ICD-10 codes for PNES with only a minority listing conversion disorder as the diagnosis. These authors concluded that consensus is lacking and that clinical guidelines for approach to diagnosis of PNES in children is needed. In a second study on PNES in children, Plioplys and her colleagues compared children with PNES from multiple study sites to their siblings to identify the risk factors for developing PNES. A study utilizing a control group of any type had not been done in the past. Children with PNES were different than their sibling controls in several ways: they were more likely to miss school, they took more prescribed and over-the-counter medications, and they had more anxiety disorders, depression, and post-traumatic stress disorder (PTSD) diagnoses, epilepsy and other illnesses, as well as adversities, such as bullying. Those with PNES used coping strategies that included avoidance and "venting, " unlike their siblings.
As found in Wichaidit et al., pediatricians are not well informed about PNES, disagree on what to call it, how to diagnose it, and what to do about it. The recent ILAE paper on diagnosing PNES without requiring VEEG (6) may not apply to children who may have more comorbid epilepsy and are less likely to have "classic PNES" motor symptoms, making the diagnosis trickier. These are age-specific questions that remain to be addressed by focused research.
While the above studies were small, it is clear that research in pediatric PNES needs to continue to focus on ways to use the same coding for diagnosis and to ensure that clinicians understand the need for the gold standard VEEG for diagnosis. To date, randomized controlled treatment trials have not yet specifically targeted children with PNES as they have for adults. Although youth with PNES have comorbid anxiety disorders and depression, the psychopathology of the conversion disorder underlying pediatric PNES differs from that of the adult illness (7) . Therefore, cognitive behavior therapy (CBT), which has been shown in randomized controlled trials to be helpful for adult PNES, may not be as helpful for children due to different underlying psychopathology and risk factors, their embedded family dynamics, as well as potential limitations in ability findings highlight the complex biopsychosocial and distinct vulnerability profile of pediatric PNES. They also underscore the need for screening the interrelated risk factors included in the somatopsychiatric and adversity components and subsequent mental health referral for confirmation of the diagnosis and treatment of youth with PNES.
to actively participate in CBT with children in the youngest age range. Further studies of pediatric PNES diagnosis and best treatment strategies are clearly needed.
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